Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-25-001077
Filing Date
2025-12-11
Accepted
2025-12-11 16:11:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4074
  Complete submission text file 0001969223-25-001077.txt   5636
Mailing Address C/O INTELLIA THERAPEUTICS INC 40 ERIE STREET, SUITE 130 CAMBRIDGE MA 02139
Business Address
LEONARD JOHN M (Reporting) CIK: 0001563584 (see all company filings)

Type: 144

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37766 | Film No.: 251565105
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)